To make the most of your techUK website experience, please login or register for your free account here.
The Chancellor has announced an investment package of £650m to boost the life sciences sector, titled ‘Life Sci for Growth’, bringing together 10 different policies.
Following the publication of the Lord O’Shaughnessy’s review into commercial clinical trials and Dame Angela McLean’s review on the life science regulatory system, the Chancellor has committed £121m, made up of new and existing funding, to speed up clinical trials and improve access to data through the Clinical Trial Acceleration Networks.
This is in addition to £154m towards to upgrading the UK Biobank capabilities.
Once anounced, techUK will be responding to the call for proposals on the government’s Long-Term Investment for Technology and Science (LIFTS) initiative. Sign-up to our newsletter below to get involved.
In addition to these funding commitments, the government has stated:
techUK has recently launched its Supercharging UK Tech and Innovation campaign, convening industry leaders to navigate why UK Government have been championing the science and technology superpower rhetoric, and what this actually means for the tech sector.
It is great to see recognition of the importance of the life sciences industry in achieving economic growth matched with funding, and techUK welcomes the consolidation of strategies to provide clarity for industry and partners. The technology sector has a huge role to play in helping to deliver life sciences commitments. techUK represents hundreds of companies with innovations that can accelerate clinical trials, make better use of data for population health management, and ultimately achieve better health outcomes for citizens. The UK tech sector now adds over £150bn to the UK economy every year, making it one the UK’s highest contributing sectors, and should be seen as integral to this strategy.
We have long believed that access to data holds the key to accelerating clinical trials. This investment sends a clear and strong message to our global partners that the UK, where we have a wealth of diversity and expertise, is open for business
To get involved in techUK’s life sciences work, find out more here or email [email protected].
techUK has launched a Life Sciences workstream, bringing together members actively working in drug discovery, digital therapeutics, data and AI, or those interested in moving into this space. As the Life Sciences sector looks to introduce digital health technologies into its portfolio, techUK are shaping the conversation.
The Interoperability Working Group will work towards achieving the vision set out in NHS England’s 2022 draft standards and interoperability strategy. The group will aim to encourage the adoption of open standards and fluidity of data whilst recognising the commercial needs of members. It will also focus on demonstrating the value of interoperability to NHS senior management and improving the abilities of SMEs to implement interoperability standards.
Find out more about our work to shape the digital social care marketplace and how our members are innovating across the industry.
Sign-up to get the latest updates and opportunities from our Health and Social Care programme.
All shortlisted nominees will be invited to attend the techUK Annual Dinner on 2 July, and four winners will be celebrated on stage in front of 650+ industry and government guests.
Furthermore, the four winners will be profiled extensively across techUK communications and social channels, with further opportunities for them to take part in techUK events, videos and blogs.
